The effect of botuline toxin A in the subscapular muscle in stroke patients with shoulder complaints; a randomized controlled trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON27111

Enrollment

Registered

2005-09-07

Start date

2002-11-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Injection of 100 units of BOTOX (R) or 0.9% saline in subscapular muscle.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Stroke shoulder- or armpain longer than 1 week; 2. VAS pain 4 or higher; Glenohumeral exorotation on the affected side is limited to 50% compared to the uninvolved side; 3. 18 years or older.

Exclusion criteria

Exclusion criteria: 1. Patients that cannot answer the painquestions; 2. Patients that cannot sit.

Design outcomes

Primary

Measure	Time frame
1. Pain score (VAS); 2. Range of motion of glenohumeral joint.	—

Contacts

Public ContactH.J. Arwert

Medical Center Haaglanden, P.O. Box 432

h.arwert@mchaaglanden.nl+31 (0)70 3302000

Outcome results